In ccRCC, the dysregulation of immune checkpoint molecules has been linked to elevated indoleamine 2,3-dioxygenase (IDO) expression, which results in decreased levels of tryptophan and activation of the kynurenine pathway. This evidence concerns the gene IDO1 and nonpapillary renal cell carcinoma.